Publications by authors named "Gustavo M Wegner"
Minerva Anestesiol
October 2024
Article Synopsis
- Remimazolam is a new anesthetic agent developed to replace propofol, which has notable hemodynamic effects that may pose risks during surgery.
- A systematic review of 16 clinical trials involving 1951 patients assessed the hemodynamic impacts of remimazolam compared to propofol, revealing that remimazolam leads to lower instances of intraoperative hypotension, bradycardia, and reduced need for vasoactive drugs.
- The findings suggest that remimazolam has a safer and more favorable side effect profile than propofol during general anesthesia, making it a promising alternative.
